CSGALNACT1 Human Gene Knockout Kit (CRISPR)

CAT#: KN419296

CSGALNACT1 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.



KN2.0 knockout kit validation

  See Other Versions

KN419296 is the updated version of KN219296.

USD 1,290.00

2 Weeks*

Size
    • 1 kit

Product Images

Other products for "CSGALNACT1"

Specifications

Product Data
Format 2 gRNA vectors, 1 linear donor
Donor DNA EF1a-GFP-P2A-Puro
Symbol CSGALNACT1
Locus ID 55790
Disclaimer The kit is designed based on the best knowledge of CRISPR technology. The system has been functionally validated for knocking-in the cassette downstream the native promoter. The efficiency of the knock-out varies due to the nature of the biology and the complexity of the experimental process.
Reference Data
RefSeq NM_001130518, NM_018371, NR_024040, NM_001354475, NM_001354476, NM_001354477, NM_001354480, NM_001354481, NM_001354483, NM_001354484, NM_001354485, NM_001354487, NM_001354488, NM_001354489, NM_001354490, NM_001354491, NM_001354492, NM_001354494, NM_001354495, NM_001354496, NM_001354497, NM_001354498, NM_001354499, NR_148897, NR_148898, NR_148899, NR_148900, NR_148901, NR_148902
Synonyms beta4GalNAcT; ChGn; CSGalNAcT-1
Summary This gene encodes an enzyme that transfers N-acetylglucosamine (GalNAc) to the core tetrasaccharide linker and to elongating chondroitin sulfate chains in proteoglycans. Knockout of the orthologous mouse gene indicates that the protein is necessary for normal cartilage development and aggrecan metabolism. Mutations in this gene are associated with multiple sclerosis progression, and with mild skeletal dysplasia and joint laxity. [provided by RefSeq, Aug 2017]

Other Versions

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.